Genomic Insight Alliance for Clinical Research & Development
It is estimated that over 50 Million people around the world suffer from epilepsy, however, 1-in-3 patients are non-responsive to existing treatments.
Sanford Health and genomic data company Congenica are working to drive forward genomic insights to develop precision targeted therapies that will address these challenges.
Register for this webinar to learn about the applications of genomics to the research and treatment of pediatric epilepsy and how this innovative approach is de-risking clinical research and development to provide answers that change lives for the better.
David A Pearce
PhD, President of Innovation, Research, & World Clinic, Sanford Health
PhD, SVP Genomics Insights & Solutions, Congenica
If you can’t attend the live event, register now to get access to the recording of this webinar.